LeMaitre Vascular announced Q2 2026 results with sales of $70.4 million, a 10% increase from the previous year, driven by strong Artegraft product growth. Gross margin improved to 72.1%, and operating income rose 26% to $20.4 million. The company declared a quarterly dividend of $0.25 per share and provided positive guidance for the rest of 2026, forecasting continued sales and earnings growth. LeMaitre is expanding its international presence and sales force to support product launches and growth.
Crypto analyst Dark Defender suggests XRP's price pattern resembles those before its major rallies in 2014 and 2017, indicating it might be ready for a significant move soon. This setup appears independent of the upcoming Sept. 15 Senate vote on the ...
Crypto analyst Dark Defender highlights that XRP's price pattern mirrors setups from 2014 and 2017, which preceded significant rallies. This suggests XRP could be primed for a major move regardless of the upcoming Sept. 15 Senate vote on the CLARITY ...
BFA Law is investigating Cardinal Infrastructure Group, Inc. for potential securities fraud related to misleading statements about the performance of its acquisition, A.L. Grading Contractors. On August 11, 2026, Cardinal's stock dropped over 36% aft...
Bleichmar Fonti & Auld LLP is investigating Coastal Financial Corporation for potential securities fraud related to its banking as a service segment and CCBX partner relationships. The probe follows a sharp 43.5% stock drop on July 30, 2026, after Co...
Monad API Hub now offers pay-per-request access to 66 blockchain data services without needing accounts or subscriptions, using USDC stablecoin for payments. Powered by the x402 v2 protocol, each API call is a microtransaction settled on-chain, simpl...
